EGFR and breast carcinoma: If α6β4 functions, in part, to recognize this vascular address, EGFR may help to mediate the translocation of tumor cells into the adjacent tissue, as EGF has been shown to be a potent chemotactic factor for breast carcinoma cells [39,40].